This inventor holds 1 USPTO granted patent. Top assignee: Helixmith Co., Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sang Ho Kwon: Innovator in Antibody Development
Introduction
Sang Ho Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work focuses on enhancing the stability and efficacy of therapeutic antibodies.
Latest Patents
Sang Ho Kwon holds a patent for an "Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereof." This invention relates to an anti-c-Met antibody that demonstrates improved stability and reduced immunogenicity compared to its parent antibody, 1E4. The enhanced properties of this antibody lead to reduced production costs, minimized side effects, and improved efficacy in therapeutic applications.
Career Highlights
Kwon is associated with Helixmith Co., Ltd., a company dedicated to advancing biopharmaceutical innovations. His work at Helixmith has positioned him as a key player in the development of novel therapeutic solutions.
Collaborations
Sang Ho Kwon has collaborated with notable colleagues, including Jae-Gyun Jeong and JungHun Lee. These partnerships have contributed to the advancement of research and development in the field of antibody therapies.
Conclusion
Sang Ho Kwon's contributions to antibody development exemplify the importance of innovation in biotechnology. His work not only enhances therapeutic options but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile